Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Lactobacillaceae

ABSTRACT: Genome sequencing project for Isolates from Hiroshimana old pickles

PROVIDER: PRJDB20731 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	DRR681810_1.fastq.gz	Fastqsanger.gz
	DRR681810_2.fastq.gz	Fastqsanger.gz
	DRR681811_1.fastq.gz	Fastqsanger.gz
	DRR681811_2.fastq.gz	Fastqsanger.gz
	DRR681812_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 10

Similar Datasets

Lactobacillaceae

Project description:Lactobacillaceae Genome sequencing and assembly

| PRJNA412075 | ENA

Lactobacillaceae

Project description:Comparative Genome Analysis of Bacterias of the Lactobacillaceae family whose origin are marine hosts

| PRJNA814659 | ENA

In-host evolution of Yersinia enterocolitica during a chronic human infection

Project description:Following a pacemaker implantation, a 75-years-old patient suffered from five successive bacteremia episodes between in 1999 and 2013, during which five bacterial strains were isolated. Phenotypic and whole-genome sequencing analysis of four isolates identified the strains as Yersinia enterocolitica bioserotype 4/O:3. Phylogenetic reconstruction showed that the patient was chronically infected by the same strain, which evolved within the host during 14 years. Single-nucleotide polymorphhism (SNP) analysis indicates that the last two isolates which displayed severe growth defects in vitro and acquired resistance to quinolones, evolved in parallel and formed two independent lineages within the host. Pan-genome analysis and genome comparison showed that their common evolution was characterized by 41 small insertion/deletion events and loss of three large DNA fragments. These mutations, which may account for the observed growth defect and also for the appearance of vegetations on the pacemaker, support antibiotics tolerance. Quinolone resistance was acquired through a so far undescribed deletion in the gyrA gene. 140 genes containing mutations vertically acquired from a common ancestor were also identified in the two lineages. A phylogenetic analysis by maximum likelihood identified two genes presenting a positive selection signal, suggesting that these mutations provided a survival advantage to bacteria during chronic infection. This is the first report allowing identification of genetic changes associated to within-host adaptation of a pathogenic Yersinia species.

2025-05-26 | PXD043567 | Pride

Comparison of genomes and proteomes of whole genome-sequenced Campylobacter jejuni from different phylogenetic backgrounds

Project description:We performed whole genome sequencing on four isolates of C. jejuni, two of which were closely related phylogenetically while the remaining two were phylogenetically divergent. Genomes were closed and finished. 4-plex iTRAQ experiments were performed on the four isolates after growth on solid medium for a standard time. The research questions were: 1) how closely do the protein profiles match among the four isolates, and 2) were there any results consistent with differences in regulation among isolates.

2017-08-04 | MSV000081410 | MassIVE

Lactobacillaceae

Project description:Genomics of lactic acid bacteria isolated from European wild boar

| PRJNA544254 | ENA

Lactobacillaceae

Project description:Genomics of lactic acid bacteria isolated from honeybee products

| PRJNA544274 | ENA

Lactobacillaceae

Project description:in-house LAB mock community analysis

| PRJDB18593 | ENA

Lactobacillaceae

Project description:Lactobacillaceae Raw sequence reads

| PRJNA1101841 | ENA

Lactobacillaceae

Project description:Lactobacillaceae Raw sequence reads

| PRJNA1101842 | ENA

A multicenter translational biomarker phase II trial of regorafenib in patients with non-resectable pretreated colorectal cancer.

Project description:Primary objectives: The primary objective is to investigate circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS). Primary endpoints: circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS).

| 2533916 | ecrin-mdr-crc

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data